| scholarly article | Q13442814 |
| P2093 | author name string | de Miranda P | |
| Burnette TC | |||
| P433 | issue | 1 | |
| P921 | main subject | aciclovir | Q147101 |
| P304 | page(s) | 60-64 | |
| P577 | publication date | 1994-01-01 | |
| P1433 | published in | Drug Metabolism and Disposition | Q1261140 |
| P1476 | title | Metabolic disposition of the acyclovir prodrug valaciclovir in the rat. | |
| P478 | volume | 22 |
| Q89262805 | A sensitive liquid chromatography-tandem mass spectrometry method for the quantification of valacyclovir and its metabolite acyclovir in mouse and human plasma |
| Q35120940 | Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans |
| Q57753923 | Absorption, Distribution, Metabolism, and Excretion of the Novel Helicase-Primase Inhibitor, Amenamevir (ASP2151), in Rodents |
| Q41058515 | Acyclic nucleosides as antiviral compounds |
| Q41142734 | Antiviral therapy of acute herpes zoster in older patients |
| Q24655792 | Apical sodium dependent bile acid transporter (ASBT, SLC10A2): a potential prodrug target |
| Q34127423 | Current recommendations for the treatment of genital herpes. |
| Q89209158 | Evaluating the intestinal and oral absorption of the prodrug valacyclovir in wildtype and huPepT1 transgenic mice |
| Q51042522 | Modern prodrug design for targeted oral drug delivery. |
| Q79988509 | Regulation of the oligopeptide transporter, PEPT-1, in DSS-induced rat colitis |
| Q36642360 | Significance of Peptide Transporter 1 in the Intestinal Permeability of Valacyclovir in Wild-Type and PepT1 Knockout Mice |
| Q34029082 | Synthesis and in vitro evaluation of potential sustained release prodrugs via targeting ASBT |
| Q33525199 | Tri-partite complex for axonal transport drug delivery achieves pharmacological effect |
| Q33776931 | Valacyclovir and acyclovir pharmacokinetics in immunocompromised children |
| Q28344239 | Varicella zoster virus. Recent advances in management |
Search more.